Fosdevirine
Overview[edit | edit source]
Fosdevirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI) that was investigated for the treatment of HIV/AIDS. It was designed to inhibit the activity of the reverse transcriptase enzyme, which is crucial for the replication of the HIV virus. Although it showed promise in early clinical trials, its development was eventually discontinued.
Mechanism of Action[edit | edit source]
Fosdevirine works by binding to the reverse transcriptase enzyme of the HIV virus. This binding inhibits the enzyme's activity, preventing the conversion of viral RNA into DNA, a critical step in the viral replication cycle. By blocking this process, fosdevirine aims to reduce the viral load in patients and slow the progression of HIV infection.
Development and Clinical Trials[edit | edit source]
Fosdevirine was initially developed by Bristol-Myers Squibb and entered clinical trials to assess its efficacy and safety in treating HIV. During these trials, fosdevirine was evaluated for its ability to reduce viral load and improve CD4 cell counts in patients. However, due to unforeseen adverse effects and the emergence of drug resistance, the development of fosdevirine was halted.
Adverse Effects[edit | edit source]
During clinical trials, some patients experienced adverse effects, which included rash, hepatotoxicity, and central nervous system disturbances. These side effects, along with the potential for drug resistance, contributed to the decision to discontinue its development.
Chemical Structure[edit | edit source]
Fosdevirine is characterized by its unique chemical structure, which allows it to bind effectively to the reverse transcriptase enzyme. The structure includes several functional groups that contribute to its activity as an NNRTI.
Current Status[edit | edit source]
As of now, fosdevirine is not approved for clinical use and remains a compound of interest primarily for research purposes. The lessons learned from its development continue to inform the design of new NNRTIs and other antiretroviral drugs.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
